Beurs gesloten -
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
1.298 INR | -1,12% | -2,95% | +16,63% |
29/03 | Ipca Laboratories Limited kondigt ontslag aan van Anand T. Kusre als onafhankelijk bestuurder | CI |
29/03 | Ipca Laboratories Limited benoemt Swati Arvind Patankar tot Onafhankelijk Bestuurder | CI |
Vakgebied
Aantal werknemers: 16 167
Verkoop per activiteit
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Branded Generics
53,8
%
| 30 028 | 51,5 % | 33 597 | 53,8 % | +11,88% |
Active Pharmaceutical Ingredients
24,4
%
| 15 132 | 26,0 % | 15 217 | 24,4 % | +0,56% |
Generics
21,2
%
| 12 504 | 21,4 % | 13 255 | 21,2 % | +6,00% |
Miscellaneous
0,5
%
| 300 | 0,5 % | 298 | 0,5 % | -0,57% |
Export Incentives
0,1
%
| 302 | 0,5 % | 59 | 0,1 % | -80,34% |
Sundry Balances Written Back
0,0
%
| 32 | 0,1 % | 17 | 0,0 % | -46,06% |
Verkoop per regio
INR in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
India
52,3
%
| 30 112 | 51,7 % | 32 655 | 52,3 % | +8,44% |
Americas
10,2
%
| 6 707 | 11,5 % | 6 367 | 10,2 % | -5,07% |
Europe
9,3
%
| 5 439 | 9,3 % | 5 783 | 9,3 % | +6,32% |
Asia (excluding India)
7,8
%
| 4 615 | 7,9 % | 4 885 | 7,8 % | +5,84% |
Africa
7,6
%
| 4 754 | 8,2 % | 4 769 | 7,6 % | +0,31% |
United Kingdom
4,8
%
| 2 597 | 4,5 % | 2 998 | 4,8 % | +15,44% |
Australasia
4,4
%
| 2 476 | 4,2 % | 2 777 | 4,4 % | +12,17% |
Commonwealth of Independent States
3,5
%
| 1 598 | 2,7 % | 2 210 | 3,5 % | +38,29% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Chief Executive Officer | 68 | 02-04-80 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 16-04-03 |
Chairman | 77 | 31-10-75 | |
Chief Tech/Sci/R&D Officer | 50 | 16-10-23 | |
Chief Investment Officer | - | - | |
Ashok Kumar
CTO | Chief Tech/Sci/R&D Officer | 70 | 06-09-00 |
Anil Pareek
CTO | Chief Tech/Sci/R&D Officer | 67 | 11-09-00 |
Compliance Officer | 64 | 20-09-93 | |
Sanjay Kapadia
PRN | Corporate Officer/Principal | - | - |
Corporate Officer/Principal | 55 | - |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Chairman | 77 | 31-10-75 | |
Director/Board Member | 76 | 16-08-11 | |
Pranay Godha
CEO | Chief Executive Officer | 51 | 16-04-03 |
Chief Executive Officer | 68 | 02-04-80 | |
Manisha Premnath
BRD | Director/Board Member | 50 | 21-09-14 |
Director/Board Member | 69 | 20-10-22 | |
Director/Board Member | 78 | 29-03-19 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 253 700 000 | 132 593 199 ( 52,26 %) | 0 | 52,26 % |
Participaties
Naam | Aandelen | % | Totale waarde |
---|---|---|---|
UNICHEM LABORATORIES LIMITED 52.67% | 37 081 011 | 52.67% | 261 498 627 $ |
LYKA LABS LIMITED 36.34% | 12 024 923 | 36.34% | 17 388 159 $ |
Bedrijfsgegevens
Ipca Laboratories Ltd.
125, Kandivli Industrial Estate Kandivili West
400067, Mumbai
+91 22 6647 4444
http://www.ipca.comSector
Verkoop per activiteit
Verkoop per regio
Herzieningen van WPA
Vaira. 1 jan. | Kapi. | |
---|---|---|
+16,63% | 3,99 mld. | |
+29,31% | 684 mld. | |
+30,25% | 568 mld. | |
-3,96% | 361 mld. | |
+18,33% | 329 mld. | |
+4,41% | 284 mld. | |
+16,00% | 240 mld. | |
+9,49% | 208 mld. | |
-6,75% | 200 mld. | |
+7,73% | 166 mld. |
- Beurs
- Aandelen
- Koers IPCALAB
- Onderneming Ipca Laboratories Limited